Articles

Innovations in supportive care: cancer treatment side effects

The association between cancer treatments and dramatic side effects such as uncontrolled nausea and vomiting retains a powerful hold over public perceptions and parts of the media. Recent decades have seen a…

Articles

Can gene therapy be made to work against solid tumours?

Gene therapy to treat cancer has been on the research agenda for three decades, with the first examples having been developed in the 1990s, according to Hrvoje Miletic, Senior Consultant in Neuropathology…

Articles

Oncolytic viruses – a new wave of therapeutic possibilities

Going back to the nineteenth century there were reports that infectious diseases seemed to provide brief periods of remission for cancer patients. One case from 1896 reported that the enlarged spleen of…

Articles

Cancer-associated thrombosis: awareness and action can save many lives

Venous thromboembolism (VTE) is the second most common cause of death in people with cancer, yet it has received far less attention than other possible complications, such as infection or neutropenic sepsis.…

Articles

Will artificial intelligence revolutionise cancer therapeutics and care?

The first machine learning application in healthcare was approved by the FDA as recently as 2019 to analyse MRI images of the heart. In oncology, applications that make use of artificial intelligence (AI) are appearing thick and fast, from improving diagnostics to developing new biomarkers. The algorithms being developed could lead to significant advances and […]

Articles

Are tumour-agnostic approaches the future for oncology?

According to Francesco Pignatti, Head of Oncology at the European Medicines Agency (EMA), the term ‘tumour agnostic’ is a misnomer. The definition of agnostic in ancient greek, he argues, is ‘lacking in knowledge’. But with these new approaches, it’s not that we don’t know, “it’s a situation where we have comprehensive evidence, so in a […]